文献速递介入腹部CTDSA

经同侧经皮肝穿刺途径与经剖腹经回盲肠途径行门静脉栓塞术的比较:并发症、特征及未来肝残体积变化

Portal vein embolization via the ipsilateral percutaneous transhepatic approach versus laparotomic transileocecal approach: complications, profile and changes in future liver remnant volume.
PubMed 文献 · Br J Radiol · 2022-03-31

研究纳入42例肝恶性肿瘤患者(经回盲肠途径TIPE组22例、同侧经皮肝穿刺途径PTPE组20例),在门静脉栓塞术前后行CT和肝胆闪烁显像,比较两组未来肝残体积及并发症。结果显示两组未来肝残体积均显著增加且组间无显著差异,TIPE组手术时间显著长于PTPE组(181.4分钟 vs 108.7分钟,P<0.01)。

要点

  • 门静脉栓塞术后未来肝残体积显著增加,PTPE与TIPE两种途径间无显著差异。
  • TIPE组手术时间显著长于PTPE组(181.4分钟 vs 108.7分钟,P<0.01)。
  • PTPE组1例因出血中转TIPE;右肝切除术后门静脉狭窄或血栓共3例(TIPE组2例9.1%,PTPE组1例5%)。

核心结论

  • 无论采用何种途径,门静脉栓塞术后未来肝残体积均显著增加;PTPE是一种手术时间更短的有用技术。

研究设计与样本

  • 比较两种门静脉栓塞途径的临床研究,共42例患者(TIPE组22例,PTPE组20例),均在门静脉栓塞后行右肝切除术,术前术后重复CT和肝胆闪烁显像,比较血液检查结果及未来肝残体积指标。

诊断标准与关键数值

  • 未来肝残体积指标包括FLRCT(由CT计算)、%FLRCT(FLRCT比率)、%FLRSPECT(单光子发射CT计算的FLR比率)、FLRCT/BS(FLRCT与体表面积之比)。
  • 两组未来肝残体积增加比率:FLRCT 8.7% vs 19.2%(P=0.15,25-75百分位17.1-60.4),%FLRCT 11.2% vs 8.3%(P=0.25,6.3-13.3),%FLRSPECT 15.4% vs 19.2%(P=0.09,16.0-22.4),FLRCT/BS 33.6% vs 47.1%(P=0.19,17.2-60.4),均无显著差异。
  • 手术时间TIPE组181.4分钟 vs PTPE组108.7分钟(P<0.01,103.3-193.5),TIPE显著更长。
  • 右肝切除术后门静脉狭窄或血栓:TIPE组2例(9.1%),PTPE组1例(5%)。
  • 右肝切除术后90天内死亡:TIPE组3例(13.6%)。

临床应用与阅片要点

  • PTPE可获得与TIPE相当的未来肝残体积增加,且手术时间更短。
  • PTPE过程中可能因出血中转TIPE(原文报告1例)。
  • 术后需关注门静脉狭窄或血栓,TIPE组报告2例(9.1%)、PTPE组1例(5%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Major liver resection is an effective treatment option for patients with liver malignancy. The future liver remnant (FLR) volume and complications after portal vein embolization (PVE) were compared between the ipsilateral right portal vein (PTPE) and transileocolic (TIPE) approaches.

METHODS: A total of 42 patients (TIPE, n = 22; PTPE, n = 20) underwent right lobectomy after PVE. CT and hepatobiliary scintigraphy were repeated before and after PVE. The blood examination findings and the FLR values (FLRCT: calculated from CT, %FLRCT: FLRCT ratio, %FLRSPECT: FLR ratio using single photon emission CT, FLRCT/BS: FLRCT to body surface ratio) were compared between two approach sites. The complications and mortality were also analyzed after PVE and major right hepatectomy.

RESULTS: There were no significant differences in the patient characteristics, blood examination findings or FLR values between two groups. Adequate liver regeneration was observed without significant differences between PTPE and TIPE (increased ratio of FLRCT: 8.7% vs 19.2%, p = 0.15 [25-75 percentile: 17.1-60.4], %FLRCT: 11.2% vs 8.3%, p = 0.25 [6.3-13.3], %FLRSPECT: 15.4% vs 19.2%, p = 0.09 [16.0-22.4], FLRCT/BS: 33.6% vs 47.1%, p = 0.19 [17.2-60.4], respectively), but TIPE required a significantly longer procedure time than PTPE [181.4 min vs 108.7 min, p < 0.01 (103.3-193.5)]. However, one patient was converted to TIPE due to bleeding during PTPE. After right lobectomy, portal vein stenosis or thrombosis was noted in three patients [two with TIPE (9.1%) and one with PTPE (5%)] and three TIPE patients died within 90 days (13.6%) after right hepatectomy.

CONCLUSION: FLR volume significantly increased after PVE, regardless of the approach sites; however, PTPE is a useful technique with a shorter procedure time.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Okada, Ihara, Miyoshi, et al. Portal vein embolization via the ipsilateral percutaneous transhepatic approach versus laparotomic transileocecal approach: complications, profile and changes in future liver remnant volume. Br J Radiol. 2022. PMID: 35348358. doi:10.1259/bjr.20210854

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。